ロード中...
Angiotensin Receptor Blocker Therapy for Heart Failure Patients: Is Combination Treatment a Feasible Prospect?
BACKGROUND: The addition of the angiotensin II type 1 receptor blocker (ARB) candesartan to a angiotensin‐converting enzyme inhibitor (ACEI) has been associated with improved clinical outcomes in patients with heart failure. However many do not tolerate combination therapy and concerns have been rai...
保存先:
| 出版年: | Clin Cardiol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Wiley Periodicals, Inc.
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6653160/ https://ncbi.nlm.nih.gov/pubmed/19743497 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.20635 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|